Analystreport

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) had its price target raised by analysts at Piper Sandler from $3.00 to $8.00. They now have a "neutral" rating on the stock.

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report